Cargando…

Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients

OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients du...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kensuke, Kodama, Yasumitsu, Tanaka, Yusuke, Pak, Kyongsun, Soga, Marie, Toyama, Akira, Katsura, Kouji, Takagi, Ritsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608342/
https://www.ncbi.nlm.nih.gov/pubmed/34807914
http://dx.doi.org/10.1371/journal.pone.0260026
_version_ 1784602731748524032
author Yoshida, Kensuke
Kodama, Yasumitsu
Tanaka, Yusuke
Pak, Kyongsun
Soga, Marie
Toyama, Akira
Katsura, Kouji
Takagi, Ritsuo
author_facet Yoshida, Kensuke
Kodama, Yasumitsu
Tanaka, Yusuke
Pak, Kyongsun
Soga, Marie
Toyama, Akira
Katsura, Kouji
Takagi, Ritsuo
author_sort Yoshida, Kensuke
collection PubMed
description OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients during the stipulated timeframe were retrospectively collected from electronic medical records from February 2017 to January 2019. We compared the presence/absence of OM (OM: yes/no) between patients with and without PEMT (PEMT: yes/no) as the primary endpoint and OM severity as the secondary endpoint. The following information was surveyed: age, gender, weight loss, steroid or immunosuppressant use, hematological values (albumin, white blood cell count, blood platelets, and neutrophils), cancer grade, primary cancer site, type and use of mouthwash and moisturizer, opioid use (yes/no, days until the start of opioid use, and dose, switch to tape), and length of hospital day (LOD). The two groups were compared using Fisher’s exact test for qualitative data and the Mann-Whitney U test for quantitative data, and a significance level of p<0.05 was set. RESULTS: The group managed by PEMT had significantly lower weight loss and a significantly lower incidence of local anesthetic and opioid use and switch to tape compared with the group not managed by PEMT (p<0.05). The two groups showed no significant difference in OM (yes/no) or OM severity. The PEMT group had significantly shorter LOD at 57 (53–64) days compared with the non-PEMT group at 63.5 (57–68) days (p<0.05). CONCLUSIONS: Our results showed that PEMT did not improve OM (yes/no) or OM severity in HNC patients undergoing CCRT. However, the PEMT group had a lower incidence of grades 3 and 4 OM than the non-PEMT group, although not significantly. In addition, PEMT contributed to oral pain relief and the lowering of the risk for OM by reduction in weight loss.
format Online
Article
Text
id pubmed-8608342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86083422021-11-23 Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients Yoshida, Kensuke Kodama, Yasumitsu Tanaka, Yusuke Pak, Kyongsun Soga, Marie Toyama, Akira Katsura, Kouji Takagi, Ritsuo PLoS One Research Article OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients during the stipulated timeframe were retrospectively collected from electronic medical records from February 2017 to January 2019. We compared the presence/absence of OM (OM: yes/no) between patients with and without PEMT (PEMT: yes/no) as the primary endpoint and OM severity as the secondary endpoint. The following information was surveyed: age, gender, weight loss, steroid or immunosuppressant use, hematological values (albumin, white blood cell count, blood platelets, and neutrophils), cancer grade, primary cancer site, type and use of mouthwash and moisturizer, opioid use (yes/no, days until the start of opioid use, and dose, switch to tape), and length of hospital day (LOD). The two groups were compared using Fisher’s exact test for qualitative data and the Mann-Whitney U test for quantitative data, and a significance level of p<0.05 was set. RESULTS: The group managed by PEMT had significantly lower weight loss and a significantly lower incidence of local anesthetic and opioid use and switch to tape compared with the group not managed by PEMT (p<0.05). The two groups showed no significant difference in OM (yes/no) or OM severity. The PEMT group had significantly shorter LOD at 57 (53–64) days compared with the non-PEMT group at 63.5 (57–68) days (p<0.05). CONCLUSIONS: Our results showed that PEMT did not improve OM (yes/no) or OM severity in HNC patients undergoing CCRT. However, the PEMT group had a lower incidence of grades 3 and 4 OM than the non-PEMT group, although not significantly. In addition, PEMT contributed to oral pain relief and the lowering of the risk for OM by reduction in weight loss. Public Library of Science 2021-11-22 /pmc/articles/PMC8608342/ /pubmed/34807914 http://dx.doi.org/10.1371/journal.pone.0260026 Text en © 2021 Yoshida et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yoshida, Kensuke
Kodama, Yasumitsu
Tanaka, Yusuke
Pak, Kyongsun
Soga, Marie
Toyama, Akira
Katsura, Kouji
Takagi, Ritsuo
Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title_full Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title_fullStr Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title_full_unstemmed Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title_short Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
title_sort pharmacist involved education program in a multidisciplinary team for oral mucositis: its impact in head-and-neck cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608342/
https://www.ncbi.nlm.nih.gov/pubmed/34807914
http://dx.doi.org/10.1371/journal.pone.0260026
work_keys_str_mv AT yoshidakensuke pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT kodamayasumitsu pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT tanakayusuke pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT pakkyongsun pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT sogamarie pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT toyamaakira pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT katsurakouji pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients
AT takagiritsuo pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients